Skip to main content

Table 1

From: PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial

 

Wk 52

Wk 104

Ash score (n = 47), median (IQR)

0.00 (-8.70: 4.00)

0.50 (-7.50: 12.00)

Poznanski score (n = 33), median (IQR)

0.30 (-0.02: 1.03)

0.17 (0.01: 1.04)

ACR Pedi 70 (n = 112), n/N (%)

92/106 (86.8)

57/65 (87.7)

ACR Pedi 90 (n = 112), n/N (%)

67/106 (63.2)

46/65 (70.8)